Symbol
Kymera Therapeutics, Inc.
Full name of the company.
MEDICAL-BIOMED/GENETICS
Industry name
DRUGS
Major industry name
Medical
Sector name
$22.07
Current price of the stock
$1M
Trading volume of the stock
$1.7B
Market capitalization of the company
Small Cap
Category of market capitalization
10.48%
Long-term growth mean estimate
4.62
Mean analyst rating
162.35%
Potential price appreciation based on analyst price targets
-
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
0.00
Total debt to total equity ratio
8.55
Current ratio
100.00%
Gross profit margin
-1927.93%
Operating profit margin
-1927.93%
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-1670.33%
Pretax profit margin
-1670.33%
Net profit margin
-7.00%
Measures profitability relative to shareholders' equity
-7.00%
ROE excluding intangible assets
-6.04%
Measures profitability relative to total assets
-6.98%
Measures profitability relative to invested capital
0.00
Asset turnover ratio
-
Inventory turnover ratio
-
Receivables turnover ratio
-
Average number of days it takes to collect receivables
-9.43
Measures valuation relative to earnings
-5.67
P/E based on future earnings estimates
19.19
Measures valuation relative to sales
1.60
Measures valuation relative to book value
-4.25
Measures valuation relative to operating cash flow
-3.55
Measures valuation relative to free cash flow
0
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC
